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Introduction
Mobile phone platforms are becoming an important method for patient monitoring in cases of chronic disease to improve and facilitate communication between providers and patients [1, 2] .
Although mobile phone platforms are used in a wide variety of settings, there are few studies that focus on the development process of the mobile phone platforms for disease management and health monitoring. The development can be seen as a way of inscribing the intentions of involved actors (laypersons, researchers and others) into a technology in order to provide support involving lay and scientific knowledge [3, 4] . From a global perspective, hypertension was the largest risk factor for cardiovascular disease [5] and mortality [6] in 2010. The case studied here was a development process of a mobile phone platform to support the selfmanagement of hypertension. The research approach was a longitudinal "real-time ethnography" method of description and analysis focusing on the appearing actors and intentions in this kind of process.
Related studies

Mobile phone platforms in chronic illness
Previous studies have shown that mobile phones and text messaging can be effectively used to improve health outcomes and the process of care [7] [8] [9] [10] [11] . Mobile phone platforms have been developed for use in the management of cancer and asthma as well as in the care of older people [1, 2] . Chronic diseases such as asthma and diabetes, as well as smoking cessation [9] , which require ongoing support and advice, benefited the most from these kinds of interventions [12] .
More often than not, as in the case of a mobile phone platform to control obesity, the research focus is on the result or design only in a technical sense, rather than the development process [13] . Alternatively, the focus is on a rather distant account of the phases of the development process [14] . Regarding the monitoring of patients with hypertension, Logan et al. [15] offer a somewhat deeper description of the design principles and technical architecture as well as the quantitative outcome of a pilot study. Alternatively, Logan [16] pursued a principal discussion of mobile phone platforms in hypertensive care as part of inventing new technologies and forms of organizing care. However, a more in-depth description of actors and intentions in the development process of mobile phone platforms in general, and for hypertension in particular, is absent.
The development of decision support for patients
A broader theme serving to contextualize this study is research on processes during which technological decision support for patients is developed. Concerning the organizational aspects of development processes, Elwyn et al. [17] and Ekberg et al. [18] proposed ideal models of activities. Berry et al. [19] and Berg et al. [20] described development processes of Web-based decision support, providing an overview of phases. Pasternack et al. [21] described "the process and the challenges" when developing decision support, noting the risk of lack of feedback from patients as well as the need for careful thinking in selecting what to include in the design.
Lehoux et al. [22] Regarding those who participate in the development processes, often discussed using the concept of Participatory Design (PD), this can be explored in several ways [23] . There are sometimes explicit forms of participation by clinicians [17, 18, 24] . Studies might also distinguish between providers or actors in possession of medical knowledge and others. Shah et al. [25] discussed this in terms of benefits of and barriers to patient participation, whereas Torsi et al. [26] discussed patients' experiences and how they can be incorporated into design.
The issue of participation thus includes actors with both medical or scientific knowledge and lay knowledge [3, 4] . In contrast, there is a lack of "real-time ethnography" studies of development processes [27] with a focus on those who participate, and their intentions and forms of knowledge [3, 4] .
In sum, what really happens in such processes -in contrast to ideal models or ex post facto rationalizations of development processes, participating actors and their intentions -seems unclear. The purpose was to get a deep and naturalistic account of the content of this kind of development process.
Aims and research questions
The aim of this study was to enhance the knowledge regarding actors and intentions in the development process of a mobile phone platform for self-management of hypertension. Two research questions have guided our analysis: 1) What actors appeared in the different phases of the development process?
2) What were the most prominent intentions or ideas actors brought up and tried to inscribe into the technology?
Methods
Analytical framework and research approach
ANT helps to conceptualize how different realities are experienced and enacted by different actors during the course of a process of, for example, technology development, including an appreciation of technologies as important [28] . ANT has informed the theoretical approach in this study, with particular emphasis on the following concepts: the process of translation, the actor (human/technical), and the concept of inscription [29] [30] [31] [32] . ANT is a rich theory that first emerged in seminal texts by authors such as those cited above. More recently, Callon and Muniesa [33] and Czarniawska and Hernes [34] have made specialized contributions. This study applied certain basic concepts of ANT to a process in a field of praxis (the development of a mobile phone platform and associated technologies to manage hypertension). We argue that ANT studies often apply a number of concepts, increasing their theoretical complexity without gaining explanatory capacity. Our minimalistic or pragmatic [28] approach is the basis for the analysis of the actors and intentions in a development project. Authors [28] have recommended the application of ANT in health care research as useful in understanding the complexity of its organizational contexts, including the role of technology.
ANT has an equal, or symmetrical [29, 30] , focus on humans and technologies. During processes of development like the one studied here, actors pursue their own interests, which they try to translate into social and technical arrangements. An inscription [31, 35] can be explained as a form of intention or anticipated behaviour that actors try to build into, for example, technical artefacts (e.g., the mobile phone platform) by means of such arrangements.
If we want to understand such processes, we must empirically follow the ways actors relate to each other and the intentions brought forward. Therefore, our research approach was a longitudinal, "real-time ethnography" method [27] of data collection and, subsequently, analysis. In this approach a researcher closely follows the events through observations, interviews and document analysis during the course of an innovation process of some kind. In this manner, it was possible to "follow the actors" closely and capture controversies and tensions as well as the general unfolding of the events they argue. A more general argument for this approach was the value of attaining a better notion of "practice".
Material and participants
The development process involved several types of patient, provider, expert and researcher (Table 1) The study included a case involving the development of a mobile phone platform in which patients are to register data on blood pressure, symptoms, side effects and wellbeing. The research programme also included the other two types of technology (a device for measuring blood pressure and a Web-based platform for looking at graphs). These are not focused on in detail in this particular study except when they were mentioned during the design meetings.
They were indeed used with the mobile phone platform, but this use took place after the development process.
The research programme entailed an intention to explore hypertensive patients' and health care providers' experiences and views regarding aspects of hypertension and hypertension treatment to be used in the development of a technology to support the management of hypertension. In this endeavour, focus group interviews were pursued (three with patients, two with providers, lasting 1.5-2 h) during April-August 2010. Fifteen patients were recruited, through an enquiry by their treating physician, from a primary health care centre and an outpatient medical clinic in Sweden. The inclusion criteria for patients were: >30 years of age and currently using drugs for hypertension. Twelve health care providers were recruited from the same units as the participating patients, and comprised equal numbers of physicians, nurses and pharmacists. The providers had to have experience of care for patients with hypertension [36] .
Between November 2010 and August 2011, 10 design meetings (lasting 1.5-2.5 h) were held with participating researchers and technical experts. The participants in these meetings were two technical experts, one expertise nurse for hypertension and researchers from the following disciplines: health and care science (n=4), education science (n=2), psychology (n=1), pharmacology, outcomes research (n=1), medicine (n=1) and theory of science (n=1).
The focus group interviews, patient interviews and design meetings were recorded and transcribed. The questionnaire to be used in the self-report system was pre-pilot tested by two patients and pilot tested by 19 patients. These 21 patients, who met the criteria of currently being medically treated for hypertension, were asked by their treating provider to participate in the cognitive interviews [37] . Even though these rich sources of data were included, there is a limitation in that additional informal communication by e-mail and telephone was not included due to practical reasons.
( Table 1 approximately insert here)
Analysis
The main author analysed the transcriptions of the focus groups and design meetings in detail, focusing on the involved actors (patients, providers, researchers and others) and their main intentions inscribed in the design of the technology to manage hypertension. The main author also analysed a summary of the transcribed patient interviews in this manner. The emergent development of the self-report questions was traced, resulting in a final version in August 2011.
Cresswell et al. [28] acknowledged the problems involved with capturing the full picture of social reality. The description of the process and analysis was informed by the ANT framework, considering the basic concepts of actors and inscriptions. However, ANT can help researchers "zoom in" on particular aspects of how networks of human and technological actors are formed by closely "following the actors" in a very concrete manner in the development process [27] .
Two specific questions guided our qualitative analysis: 1) What actors appeared in the different phases of the development process from the start to the finalization of the self-report questionnaire in the mobile phone platform? and 2) What were the most prominent intentions or ideas actors brought up and tried to inscribe into the technology? These questions mean that the ambition has been to provide a fair and representative account of the rich empirical material (3.1), as a foundation for further analysing the actors and intentions (3.2). In practice, the actors appearing were simple to capture. Regarding the intentions or ideas, the first author pursued a simple coding of the recurring themes at the highest relevant level ("discussion about the project aim", "discussion about the telephone questions" etcetera). The account produced in Section 3.1 served as a means to show the actual instances or content of these general themes.
Admittedly, such an analysis can be made at different levels and in various levels of detail [28] .
This qualitative study was based on a large amount of material, as described above. However, instead of a brief overview of processes and technologies as is often done in previous research (see Section 1.1), here we get a theoretically informed account of meetings and citations from participants (3.1), as well as a table presenting an overview (Table 2) as a foundation for analysis and result.
(Table2 approximately insert here)
Ethics
The research programme was approved by the Regional Ethics Board in Gothenburg, Sweden (study code 551-09). The patients and providers were given written and oral information regarding voluntary participation and explaining that their responses would be confidential. The experts and researchers were informed orally. The research programme was planned and conducted in accordance with the Declaration of Helsinki [38] .
Results
1 An account of the development process
Hypertension is a serious condition that demands long-term medication. However, many patients feel that the antihypertensive medication itself causes trouble through side-effects, resulting in poor adherence to treatment [39] . With this as a background, Kjellgren et al. [40] conducted a study of patients with and without antihypertensive medication and found that both categories perceived symptoms. It was suggested that future studies focus on patients' more exact perceptions of treatment.
In an approved research application, Kjellgren and colleagues outlined a research programme entitled "Mastery and autonomy in medication with a mobile self-report system" [41] . It was argued that patients' perceptions of their illness and treatment may be the key to addressing the question of adherence. Tools for monitoring illness and treatment might therefore need to take these factors into account. The self-management system can be used for this purpose, for example by means of a mobile phone platform. In this endeavour, the research programme would design and evaluate such a technology to support hypertensive care [41] . 
Focus group interviews with patients
The main researcher in Health Care Science and a technical expert working with the mobile phone platform participated in these interviews. The patients were generally satisfied with their current anti-hypertensive treatment, saying that the most important things were to feel safe, to have regular check-ups and to have good contact with a physician. When asked about their symptoms a few mentioned dizziness, heart palpitations, tiredness and headaches. Patients felt that the symptoms mentioned were good candidates for questions to ask via the mobile phone platform, and were explicitly requested to rank a list of suggested symptoms. These listed symptoms emanated from a population-based multicentre study of perceived symptoms amongst hypertensive patients [40] .
The researcher also tried to elicit the patients' general feelings about the research programme idea by asking questions and explaining.
HCS1: What do you think about this way of following up on the medication? PAT: I must say that I didn't fully understand it. I don't have a mobile now, but I used to.
[ expressed a desire to answer rather seldom (once a month or once a week); but when the researcher explained that they would have to answer questions much more often than this, they expressed understanding.
Focus group interviews with providers
Also here, one main theme concerned symptoms of hypertension and hypertensive treatment.
The general view among providers was that symptoms are rare, except for headache, stress and dizziness. As for side effects from treatment, these might also include headache and dizziness.
It was considered important to follow up blood pressure measurement. Regarding adherence, the view was that many patients followed instructions but that there was great variation in this.
Figures between 30 and 50% non-adherence were mentioned.
The technician explained in detail about the different types of questions and answers that could be put into the mobile phone platform. When asked what should be put into the platform, the providers suggested topics such as tiredness, dizziness, headache and sleep.
Concerning the issue of the general idea of the research programme, the results were mixed: At Meeting 4, the discussion about the best scale to use (VAS or Likert) resurfaced. This was connected partly to scientific reasons and partly to the mobile phone platform. It was argued that smart-phone technology made it easier to use different scales without risking the corruption of the question layout.
A further issue was a visiting expert nurse's presentation of the patients' measurement of their own blood pressure. The main researcher explained:
HCS1: And this is the main intention; that the patient becomes aware of the blood pressure they have -register it in the mobile phone and can look at it on the graphs.
Interestingly, the issue of the larger aim of the project was brought up once again, by HCS1:
"This is a design study, not a clinical controlled study. We want to bring forward knowledge from this design."
At Meeting 5 different aspects of the mobile phone questions were discussed, for example regarding the motivational messages but also the response scale. How different questions should be selected according to the patient's personal situation was also discussed: PSY: "So the expectation is that the physician takes the set of questions that he feels is applicable to this patient?". It was suggested that the mobile phone questions be more clearly related to the research programme and its aim:
PHA: So that's one hypothesis, then. […] To build up this kind of model where you relate all the symptoms that are important and you also construct the conceptual framework of all the questions […] so you don't miss anything.
At Meeting 6, the questions to be tested in the pilot study had been put in the mobile phones application in preparation for the pre-pilot interviews. When discussing the information leaflet to be shown to participating patients, the description of the project aim was brought up:
TS: The questions will be answered by patients in the mobile. […] You say it's about improved adherence. But this research programme is also about patients gaining better control over their knowledge to become "Master and Autonomous."
The discussion about the motivational messages continued: 
Pre-pilot cognitive interviews
At two pre-pilot interviews, patients were given the opportunity to test the different questions using a borrowed mobile phone, as well as to measure and register their own blood pressure.
Afterwards a detailed interview was held. Some questions and motivational messages ("Have you done any yoga, read, cooked lunch?") were characterized as irrelevant by one of the patients.
Design Meeting 7 with researchers
During this meeting, the two pre-pilot interviews with patients were referred to. One issue was the importance of communicating the aim of the research programme. It was argued that the issue of the graphs with patient data, accessed via the Web, had disappeared in the interviews.
The views of the two interviewed patients about the motivational messages (one in favour, one more vague) were referred to. The risk that these messages would affect the results of the study was also brought up, but it was suggested that they could be omitted or tailored to the individual patient. It was determined that the main researchers and one technician should be consulted about their inclusion.
Pilot cognitive interviews
Pilot interviews were held with 19 patients, during which the patients had the opportunity to test the questions. A first question about wellbeing was interpreted as either more general or closely related to hypertension. Some of the response alternatives were discussed, for example "partly" taking one's medicine and a "neither-nor" alternative. Some questions about side effects of medication were regarded as irrelevant to certain interviewees. The wording of questions and answers about "physical activity" was questioned. Lastly, patients' views about motivational messages were rather positive.
Design Meetings 8-10 with researchers
At Meeting 8, the pilot interviews with patients were further discussed. The rationale behind these interviews was described as focusing on the emergent learning about patients' views on questions.
The motivational messages were discussed and the patients' responses were referred to: 
An analysis of the development process
Participating actors
Our account shows that hypertensive patients, providers, experts and researchers (Table 1) took part in the development process. The patients participated in focus groups aiming to get input on the design of appropriate questions. They also took part in pre-pilot and pilot interviews, commenting on the appropriateness of the proposed questions, the answer models, the motivational text message and the ease of answering from a technological point of view. The providers participated in focus groups discussing virtually the same issues, but expressed scepticism regarding the existence of symptoms and the use of mobile phones.
In contrast, researchers from various disciplines took part in the whole process through focus group interviews, pilot interviews and design meetings. The researchers were made up of a core group within Health and Care Science and Theory of Science. An outer circle of researchers representing pedagogy, psychology, medicine and pharmacology also took part on certain limited occasions. A further group was comprised of experts on the mobile phone platform. Their focus was on presenting the platform as well as helping in the development of questions.
The composition of these actors relates to the issue of how both lay and scientific knowledge [3, 4] are part of the processes in which decision support for patients is developed. It can be concluded that development processes might involve patients, providers and researchers as well as technicians, thus being a part of PD practices [23] . The actors, with their respective types of lay, scientific and technological knowledge, can be actively involved as a rationale behind the process organization. In our study, PD was part of the argument behind the research programme's emphasis on the necessity to capture patients' own beliefs [41] , the applied FDA model for development (Meeting 2) and the intention to anchor the technology among providers so it will be accepted in clinical praxis (Meeting 10). It might also be part of a more general understanding of how to organize these kinds of development processes [19, 21] . Despite this presence of PD practices we can also see how, with the main exception of researchers in Health Care Science, the patients might be active in comparatively distinct and limited parts of the development process (focus group discussions, patient interviews). The participation of patients might thus be limited in time as well as conceptually, even though patients' perceptions are an important aspect of the motivation for the study.
Intentions
Interestingly, the intentions the actors brought up and wanted to inscribe into technology (3.1)
did not vary much during the course of the process (Table 2 ). In the focus groups there was a dialogue between researchers, technicians and patients about the appropriate questions to be put into the mobile phone platform and the idea of hypertensive patients using mobile phones 
Discussion
In the development process there was deliberation regarding the mobile phone questions with regard to the features of the mobile phone platform allowing for certain lengths of questions and standards of answering, but also the scientific aim of designing valid questions. There was also deliberation regarding the motivational messages with regard to the features of the platform offering this opportunity, the scientific aim of designing valid questions and the aim of designing a clear cause-and-effect relationship between the questions. Furthermore, there was deliberation regarding the fact that the features of the mobile phone platform offered the opportunity to answer questions easily. However, this was deeply dependent on the whole constellation of involved technologies, and the scientific need to make the entire aim of the research programme clear and implement it. To conclude, the actors' discussion of intentions might thus focus on a few concrete issues at the same time as it contains tensions related to the affordances of the motivational technology [43] as described. Navigability, interactivity and customization are examples of affordances of such technology that are explicitly said to have a positive effect on users' motivation [43] . In our study, the affordances in the form of the mobile phone platform's capacity to support easy questioning and answering as well motivational messages offered options for design and use. At the same time, they encompassed limitations of design and use, as well as affected the scientific and causal model that was constructed.
The results thus showed that not only the patients, researchers and technology experts but also the technologies themselves might be important as viable affecting the discourse and the emergent definition of central intentions related to, for example, the research programme aim and the mobile phone questions (Table 2 ). In fact, in a subsequent three-month user evaluation of the mobile phone platform, the order of the questions has once again been changed due to the affordances of the technology, with the measurement of blood pressure having to be done first instead of last. The role of technology as an actor is not a conclusion based on technological determinism or ex post facto rationalization. Instead, it is based on the concrete experiences of following the actors in an innovation process [27] and their discourse related to the design. We argue that this manner of studying innovation processes helps uncover otherwise hard to detect controversies as well as choices made by situated actors. The role of technology as a fully fledged actor affecting important aspects in projects developing decision support for chronic patients, as in our case here, might be seen as the most important result of this.
Against the background of our analysis, it can also be concluded that the greater result of the development process of a technology for managing hypertension expressing the intentions of participating actors can be summarized as follows:
1) Questions and answers in a mobile phone platform. In the case studied here, these were developed against the background of previous research and focus groups fit for inclusion in clinical studies [19] . This was a result of both patients' (lay) and researchers' (scientific) knowledge and input.
2) A more indirectly emerging causal model made up of issues of interest to be measured in a scientific project. This discussion had only begun during the above-discussed period of the design meetings in our study.
3) A first step in a researcher-initiated attempt to support learning and offer the capacity to act through a mobile phone platform and accompanying technological devices. Further, a finding in studies concerned with the relationship between lay and scientific knowledge like ours, relying on a co-production model through the use of PD, is that universal scientific knowledge can be challenged or modified by lay knowledge [44] . This is because scientific recommendations are of a contextual aggregated character. This means that such recommendations are not always appropriate, and are therefore not followed, in the multifaceted reality of everyday life. From an education model, this is often interpreted as a lack of adherence by an individual patient. An important and very difficult task in PD would therefore be the issue of how to generalize or aggregate particularity as expressed by the layperson. In our study as well as in others, it is investigated how patients themselves, via focus groups, have been encouraged to reach a general level rather than a personal, individual one. On the other hand, in our case, the technology produces "individual" graphs whereby this individuality is conditioned or controlled as part of the scientific interest. Another example of this is the patients' suggestion that, based on their lay experience, it would be appropriate to answer the telephone questions monthly or weekly. From a scientific or research point of view, this is not adequate.
To conclude, treatment models involving a self-management system might express a tension between lay and scientific knowledge even if patients are given an important role in the -24 -development process. In the case studied here, one could argue that this tension is also represented in the greater intention to enhance patients' mastery and autonomy while simultaneously increasing adherence. We indeed have a paradox here, since these two intentions are seemingly contradictory. Instead, we argue, their relationship is close when considering the actual goal, which in the particular case studied here was to ensure wellcontrolled blood pressure.
It is important to acknowledge that patients' actual capacity to act that is attained in projects developing systems for managing chronic illness will depend on how the constructed "treatment model" is to be further developed after the clinical testing. The actual results, of course, will also partially depend on the appropriation of technology in institutionalized use in patients' own life situations [45] . The symmetrical ambition of our applied theoretical framework [29, 30] offers an explanation of our joint result of actors and intentions: both humans and technologies play important roles, as discussed above.
Lehoux et al. [22] showed the nuances of participating actors' knowledge and roles in creating a "medical instrument" or object. In contrast, here, by following a process of development studied using "real-time ethnography" methods, we conclude that the appearing actors and their knowledge are not only multifaceted but also the result of the development as described. Concerning previous studies on mobile phone platforms in the management of chronic illness in general, and hypertension in particular, we have contributed by offering an in-depth review of actors and intentions. This complements previous research [13] [14] [15] [16] with a focus on technical design, distant descriptions of development processes, and outcomes.
There are limitations to this study: the results are based on a single case study. However, they show an account of actors and intentions, which hopefully mediates the naturalistic character of the development process. Further studies might involve a comparative case approach involving two to four similar cases of development. An interesting issue would also -25 -be a study of real use and users [28] , evaluating the long-term effects on patient autonomy and mastery.
Conclusions
Our study showed that laypersons, experts and scientific actors as well as technology itself influence development processes of support for patients in managing hypertension. The intentions were inscribed into technology design as well as models of learning and treatment.
This illustrated the multifacetedness of the results of such projects. During the course of the process, tensions emerged in the translation from lay knowledge, generated by PD, to scientific knowledge in the later phases. We have also detected the apparent "paradox" of introducing a self-management system for hypertensive patients and the intention to increase adherence. Table 1 . Events and participating actors in the development process Table 2 . Overview of the development process Figure 1 . Overview of the self-management system. The system consists of:
Legends
4. Mobile phone platform for the self-report questions and the optional motivational messages.
5. Blood pressure device.
6. Web-based platform for real-time visualization of the patients' reported data via line graphs.
